Entera Bio Ltd.
NASDAQENTX utilization hits 100%, tied to 52-week high, with availability plunging 87% in one week to just 3.8% — shares extremely hard to borrow.
Entera Bio has become one of the more striking small-cap biotech setups of the summer — a stock up 65% in a month while short sellers pile in at a pace not seen in years. The lending market tells the most urgent story…
Entera Bio enters May 14 earnings week with an unusual combination: shorts pulling back sharply, the stock up 18% on the week, and a 19.6 million share secondary filing landing the same afternoon as Q1 results. That…
Snapshot as of 22 Sept 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ENTX — free to start on ORTEX.
Sign up for free →Open ENTX on ORTEX